Effects of allergic diseases, concomitant with allergic rhinitis, on the clinical efficacy and costs of allergen-specific immunotherapy in Poland

Postepy Dermatologii i Alergologii

Volumn 28, Issue 5, 2011, Pages 378-381

  Jahnz Rozyk, Karina ^a   Targowski, Tomasz ^a   Owczarek, Witold ^a   Przekora, Piotr ^a   Kucharczyk, Aleksandra ^a   Wesołowski, Adam ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Allergic rhinitis; Allergy; Atopic dermatitis; Bronchial asthma; Specific immunotherapy; The oral allergy syndrome

Indexed keywords

ALLERGOVIT; POLLEN ANTIGEN; UNCLASSIFIED DRUG; VACCINE;

ALLERGIC RHINITIS; ALLERGY; ARTICLE; ASTHMA; ATOPIC DERMATITIS; DRUG COST; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; ORAL ALLERGY SYNDROME; POLAND; SYMPTOMATOLOGY; TREATMENT RESPONSE;

EID: 81255192077     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63 Suppl 86: 8-160.
2. Crystal-Peters J, Neslusan CA, Smith MW, Togias A. Health care costs of allergic rhinitis-associated conditions vary with allergy season. Ann Allergy Asthma Immunol 2002; 89: 457-62. (Pubitemid 36187987)
3. De Longueville M. ETAC Study Group (Early treatment of the Atopic Child). What are the candidate groups for pharmacotherapeutic intervention to prevent asthma. Pediatr Allergy Immunol 2000; 11 Suppl 13: 41-4.
4. Pajno G, Barberio G, De Luca F, et al. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001; 31: 1392-7. (Pubitemid 32823876)
5. Des Roches A, Paradis L, Menardo JL, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997; 99: 450-3. (Pubitemid 27173080)
6. Bousquet J, Lockey RF, Malling HJ. World Health Organization Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53 (Suppl. 54): 1-42. (Pubitemid 28346358)
7. Calderon MA, Alves B, Jacobson M, et al. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007; 1: CD001936.
8. Canonica GW, Baena-Cagnani CE, Bousquet J, et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of aWorld Allergy Organization (WAO) taskforce. Allergy 2007; 62: 317-24.
9. Bussmann C, Böckenhoff A, Henke H, et al. Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol 2006; 118: 1292-8. (Pubitemid 44854122)
10. Silny W, Czarnecka-Operacz M, Gliński W, et al. Atopic dermatitis - contemporary view on pathomechanism and management. Position statement of the Polish Dermatological Society specialists. Post Dermatol Alergol 2010; 27: 365-83.
11. Czarnecka-Operacz M, Silny W. Specific immunotherapy in atopic dermatitis: four-year treatment in different age and airborne allergy type subgroups. Acta Dermatovenerol Croat 2006; 14: 230-40. (Pubitemid 46154746)
12. Novak N. Allergen specific immunotherapy for atopic dermatitis. Curr Opin Allergy Clin Immunol 2007; 7: 542-46. (Pubitemid 350076451)
13. Samoliński B. Epidemiologia nieżytów nosa, astmy i AZS na podstawie badań ECRHS i ISAAC w Polsce. Alergia 2007; 3: 10-2.
14. Samoliński B, Raciborski F, Tomaszewska A, et al. The incidence of allergy in Poland - ECAP program. Alergoprofil 2007; 3: 26-8.
15. The European Lung White Book. Asthma burden. Available at: www.ersnet.org.
16. Jahnz-Różyk K. Farmakoekonomika rozpoznawania i leczenia chorób alergicznych. Alergia Astma Immunologia 2006; 11 (supl. 1): 56-8.
17. Patterson R. The role of immunotherapy in respiratory allergic diseases. J Allergy Clin Immunol 1998; 101: 403-4.
18. Crystal-Peters J, Neslusan C, Crown WH. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthmarelated hospitalizations and emergency department visits. J Allergy Clin Immunol 2002; 109: 57-62. (Pubitemid 34112130)
19. Hankin CS, Cox L, Lang D, et al. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study. Ann Allergy Asthma Immunol 2010; 104: 79-85.
20. Ariano R, Berto P, Tracci D, et al. Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma. Allergy Asthma Proc 2006; 27: 159-63. (Pubitemid 43700869)